| Code | Description | Claims | Beneficiaries | Total Paid |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
28,875 |
25,216 |
$2.04M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
2,989 |
2,649 |
$1.31M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
977 |
934 |
$1.25M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
2,379 |
2,317 |
$995K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
7,051 |
6,651 |
$873K |
| 70450 |
Computed tomography, head or brain; without contrast material |
3,254 |
3,112 |
$809K |
| 0450 |
Emergency room services |
13,916 |
12,661 |
$698K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
5,626 |
5,297 |
$541K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
1,661 |
1,505 |
$439K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
1,708 |
1,682 |
$382K |
| 99199 |
Unlisted special service, procedure or report |
3,096 |
2,674 |
$344K |
| 80053 |
Comprehensive metabolic panel |
21,093 |
19,702 |
$325K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
4,293 |
3,925 |
$312K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
4,008 |
3,897 |
$302K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
8,398 |
7,844 |
$298K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
1,558 |
1,473 |
$253K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
1,201 |
1,194 |
$237K |
| T1999 |
Miscellaneous therapeutic items and supplies, retail purchases, not otherwise classified; identify product in "remarks" |
14,344 |
8,956 |
$230K |
| 71045 |
Radiologic examination, chest; single view |
6,048 |
5,819 |
$221K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
23,827 |
21,695 |
$217K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
3,725 |
3,439 |
$214K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
779 |
748 |
$188K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
3,037 |
2,807 |
$182K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
1,435 |
1,404 |
$144K |
| 82077 |
|
2,735 |
2,635 |
$127K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
3,482 |
3,382 |
$125K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
3,457 |
3,359 |
$124K |
| 71046 |
Radiologic examination, chest; 2 views |
2,539 |
2,473 |
$112K |
| 83880 |
|
1,916 |
1,820 |
$89K |
| 84484 |
|
6,117 |
4,631 |
$80K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
6,439 |
5,911 |
$78K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
190 |
187 |
$69K |
| 83690 |
|
7,173 |
6,761 |
$65K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,542 |
1,502 |
$55K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
3,518 |
3,199 |
$53K |
| J3490 |
Unclassified drugs |
3,324 |
2,203 |
$47K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
5,208 |
4,667 |
$46K |
| 84443 |
Thyroid stimulating hormone (TSH) |
4,066 |
4,021 |
$40K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
4,473 |
4,298 |
$38K |
| 80061 |
Lipid panel |
4,669 |
4,635 |
$33K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
3,684 |
3,404 |
$33K |
| 80143 |
|
403 |
397 |
$30K |
| 81025 |
|
4,945 |
4,791 |
$30K |
| 0270 |
|
1,086 |
704 |
$29K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
415 |
411 |
$29K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
5,579 |
5,535 |
$29K |
| 81001 |
|
7,410 |
7,103 |
$28K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
727 |
716 |
$28K |
| 87040 |
|
1,496 |
906 |
$27K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
2,732 |
2,613 |
$26K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
940 |
821 |
$24K |
| 94060 |
|
170 |
169 |
$23K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
2,050 |
2,033 |
$23K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
293 |
291 |
$23K |
| 83605 |
|
1,555 |
1,242 |
$21K |
| 83735 |
|
2,093 |
1,880 |
$20K |
| 80179 |
|
405 |
398 |
$19K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
1,436 |
1,312 |
$18K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
179 |
177 |
$17K |
| 84702 |
|
2,186 |
1,912 |
$17K |
| 76830 |
Ultrasound, transvaginal |
264 |
260 |
$16K |
| 73030 |
|
355 |
342 |
$16K |
| 94726 |
|
213 |
211 |
$16K |
| 73610 |
|
486 |
476 |
$16K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
41 |
40 |
$15K |
| 81003 |
|
4,730 |
4,580 |
$13K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
1,917 |
1,911 |
$12K |
| 85610 |
|
2,604 |
2,448 |
$12K |
| 87081 |
|
1,302 |
1,274 |
$12K |
| 87186 |
|
1,309 |
1,201 |
$11K |
| 73630 |
|
356 |
349 |
$11K |
| 94729 |
|
213 |
211 |
$11K |
| G0108 |
Diabetes outpatient self-management training services, individual, per 30 minutes |
114 |
62 |
$10K |
| 85730 |
|
1,479 |
1,428 |
$10K |
| 85027 |
|
1,629 |
1,555 |
$9K |
| 83789 |
|
478 |
443 |
$9K |
| 80055 |
|
291 |
290 |
$9K |
| 87400 |
|
1,638 |
1,581 |
$9K |
| J2060 |
Injection, lorazepam, 2 mg |
931 |
869 |
$9K |
| 87430 |
|
807 |
780 |
$8K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
86 |
44 |
$8K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
813 |
755 |
$8K |
| 93797 |
|
114 |
28 |
$8K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
651 |
625 |
$8K |
| 82947 |
|
1,046 |
935 |
$8K |
| 73564 |
|
220 |
217 |
$8K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
641 |
628 |
$8K |
| 85379 |
|
483 |
476 |
$7K |
| 0250 |
|
357 |
247 |
$7K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
20 |
20 |
$7K |
| 93971 |
|
25 |
25 |
$7K |
| 73130 |
|
100 |
96 |
$7K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
73 |
73 |
$7K |
| 83970 |
|
92 |
90 |
$6K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
79 |
76 |
$6K |
| 70496 |
|
13 |
12 |
$6K |
| 82728 |
|
905 |
895 |
$6K |
| 86481 |
|
165 |
165 |
$5K |
| 86803 |
|
839 |
836 |
$5K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
548 |
521 |
$5K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
271 |
248 |
$5K |
| 84439 |
|
739 |
729 |
$4K |
| 82805 |
|
96 |
88 |
$4K |
| 82570 |
|
1,185 |
1,099 |
$4K |
| 73562 |
|
75 |
75 |
$4K |
| 99070 |
|
976 |
637 |
$3K |
| 82043 |
|
809 |
799 |
$3K |
| 86592 |
|
1,345 |
1,335 |
$3K |
| 82951 |
|
245 |
244 |
$3K |
| 86787 |
|
238 |
235 |
$3K |
| 71271 |
|
79 |
79 |
$2K |
| 87077 |
|
278 |
266 |
$2K |
| 77080 |
|
13 |
13 |
$2K |
| 85652 |
|
968 |
949 |
$2K |
| 86901 |
|
510 |
426 |
$2K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
614 |
602 |
$2K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
25 |
24 |
$2K |
| 83550 |
|
203 |
199 |
$2K |
| 90715 |
|
39 |
37 |
$2K |
| 83540 |
|
267 |
263 |
$2K |
| 87420 |
|
256 |
251 |
$2K |
| 86900 |
|
529 |
419 |
$2K |
| 82274 |
|
94 |
94 |
$2K |
| 73502 |
|
25 |
25 |
$1K |
| 71020 |
|
40 |
39 |
$1K |
| 86140 |
|
195 |
191 |
$1K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
18 |
18 |
$1K |
| 87634 |
|
20 |
20 |
$1K |
| 84550 |
|
189 |
189 |
$1K |
| 86850 |
|
179 |
177 |
$1K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
16 |
13 |
$1K |
| 82607 |
|
106 |
105 |
$1K |
| 84100 |
|
200 |
158 |
$1K |
| 87486 |
|
21 |
21 |
$1K |
| 87581 |
|
21 |
21 |
$1K |
| 86480 |
|
13 |
13 |
$997.83 |
| 0272 |
|
45 |
45 |
$996.74 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
41 |
37 |
$956.43 |
| 71010 |
|
65 |
63 |
$886.33 |
| 82550 |
|
110 |
104 |
$838.06 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
28 |
25 |
$614.52 |
| 36415 |
Collection of venous blood by venipuncture |
6,849 |
6,276 |
$605.51 |
| 86038 |
|
89 |
88 |
$583.86 |
| 84153 |
|
27 |
27 |
$577.90 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
92 |
90 |
$568.40 |
| 72100 |
|
14 |
14 |
$542.59 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
70 |
68 |
$521.59 |
| 84436 |
|
203 |
203 |
$434.81 |
| J1630 |
Injection, haloperidol, up to 5 mg |
57 |
54 |
$403.46 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
28 |
26 |
$393.97 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
44 |
39 |
$393.30 |
| 87340 |
|
96 |
96 |
$379.53 |
| 80076 |
|
63 |
62 |
$329.03 |
| 85045 |
|
57 |
54 |
$311.88 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
789 |
785 |
$269.29 |
| 87147 |
|
57 |
54 |
$228.22 |
| 83021 |
|
42 |
42 |
$218.35 |
| S0164 |
Injection, pantoprazole sodium, 40 mg |
12 |
12 |
$179.94 |
| 87210 |
|
41 |
41 |
$154.79 |
| 82746 |
|
18 |
18 |
$145.55 |
| 87088 |
|
27 |
27 |
$141.94 |
| J2470 |
Injection, pantoprazole sodium, 40 mg |
14 |
12 |
$133.11 |
| 84460 |
|
43 |
43 |
$132.37 |
| 82652 |
|
12 |
12 |
$129.16 |
| 86706 |
|
14 |
14 |
$72.41 |
| 83655 |
|
110 |
110 |
$59.97 |
| 86431 |
|
12 |
12 |
$57.84 |
| 99441 |
|
52 |
49 |
$0.00 |
| 90686 |
|
809 |
807 |
$0.00 |
| H1001 |
Prenatal care, at-risk enhanced service; antepartum management |
267 |
183 |
$0.00 |
| 92551 |
|
792 |
790 |
$0.00 |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,125 |
2,023 |
$0.00 |
| S9445 |
Patient education, not otherwise classified, non-physician provider, individual, per session |
196 |
144 |
$0.00 |
| 0250R |
|
13 |
13 |
$0.00 |
| 90688 |
|
75 |
75 |
$0.00 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
28 |
28 |
$0.00 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
12 |
12 |
$0.00 |
| G9012 |
Other specified case management service not elsewhere classified |
21 |
14 |
$0.00 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
16 |
14 |
$0.00 |
| J2704 |
Injection, propofol, 10 mg |
15 |
13 |
$0.00 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
34 |
30 |
$0.00 |
| 85018 |
|
75 |
75 |
$0.00 |
| 90698 |
|
12 |
12 |
$0.00 |
| 59426 |
|
1,972 |
1,484 |
$0.00 |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
89 |
89 |
$0.00 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
515 |
515 |
$0.00 |
| 99173 |
|
723 |
723 |
$0.00 |
| H1003 |
Prenatal care, at-risk enhanced service; education |
1,409 |
1,080 |
$0.00 |
| 90461 |
|
270 |
270 |
$0.00 |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
330 |
329 |
$0.00 |
| 99401 |
|
128 |
122 |
$0.00 |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
256 |
256 |
$0.00 |
| 90633 |
|
38 |
38 |
$0.00 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
13 |
13 |
$0.00 |
| 99442 |
|
278 |
262 |
$0.00 |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
84 |
84 |
$0.00 |
| 90670 |
|
80 |
79 |
$0.00 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
53 |
51 |
$0.00 |